| Product Name |
Finasteride EP Impurity A / Finasteride USP Related Compound A |
| Product Category | Impurities, Intermediates |
| Sub-Category | Heterocycles, Pharmaceutical Standards, Fine Chemicals |
| CAS No | 98319-24-5 |
| Catalog Number | GS.14.FIN.01 |
| Chemical Name/Synonyms | N-(1,1-dimethylethyl)-3-oxo-4-aza-5α-androstane-17β-carboxamide; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide |
| Molecular Weight | 374.56 |
| Molecular Formula | C23H38N2O2 |
| Purity | NLT 95% |
| Appearance | White Solid |
| Solubility | Methanol , Chloroform |
| Applications | The reduced product of Finasteride: a mechanism-based inhibitor of human prostate and skin steroid 5α-reductase. It forms an enzyme-bound NADP-dihydrofinasteride adduct during this inhibitor y process. |
| Inventory Status | Ready Stock Please as a distributor to view package sizes and prices |